NeuroICH

Infervision is a leading AI medical technology company established in 2016, focusing on improving multidisciplinary services and operations with AI. They offer cutting-edge AI products that support medical professionals in all areas, from disease screening and diagnosis to intervention and treatment, patient management, and medical research. Their solutions include InferRead CT Lung for lung nodule detection from chest CT, InferRead DR Chest for detecting chest abnormalities from chest X-rays, InferRead CT Coronary for identifying coronary artery stenosis in coronary CTA, InferRead CT Stroke for triaging hemorrhage from brain CT, InferRead CT Bone for identifying chest fractures from chest CT, and InferRead CT Pneumonia for identifying and triaging pneumonia from chest CT. Additionally, they offer InferOperate for 3D reconstruction in thoracic, liver, and urological surgeries, InferCare for patient management and image follow-up, and InferScholar as an AI-enabled medical research tool.

Technology designed by clinicians, for clinicians, to dramatically improve patients’ lives. Our AI-based platform is designed for speed, scalability, and security with flexibility and customization to meet each hospital’s specific needs. It’s the long-term solution you can rely on. Make faster, more accurate triage and/or transfer decisions with the RapidAI stroke portfolio. Accelerate the process of finding, tracking and proactively treating aneurysms. Detect suspected PE cases quickly with RapidAI’s suite of products and services for PE care. AI-powered clinical decision support (CDS) software helps physicians make decisions faster, but not all artificial intelligence is alike. Only CDS tools with clinical depth identify, locate, characterize, and quantify suspected conditions with an unrivaled degree of accuracy. How AI-powered CDS modules lead to better triage and transfer decisions. The CDS tools power more accurate diagnoses and streamline vascular care.